Appili Therapeutics Stock Price Prediction
| APLI Stock | CAD 0.04 0.00 0.00% |
Oversold Vs Overbought
49
Oversold | Overbought |
Wall Street Target Price 0.15 | Quarterly Revenue Growth (0.96) |
Using Appili Therapeutics hype-based prediction, you can estimate the value of Appili Therapeutics from the perspective of Appili Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Appili Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Appili because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Appili Therapeutics after-hype prediction price | CAD 0.04 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Appili |
Appili Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Appili Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Appili Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Appili Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Appili Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Appili Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Appili Therapeutics' historical news coverage. Appili Therapeutics' after-hype downside and upside margins for the prediction period are 0.00 and 8.62, respectively. We have considered Appili Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Appili Therapeutics is out of control at this time. Analysis and calculation of next after-hype price of Appili Therapeutics is based on 3 months time horizon.
Appili Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Appili Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Appili Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Appili Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.62 | 8.58 | 0.00 | 0.00 | 2 Events / Month | 1 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.04 | 0.04 | 14.29 |
|
Appili Therapeutics Hype Timeline
Appili Therapeutics is presently traded for 0.04on Toronto Exchange of Canada. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Appili is estimated to increase in value after the next headline, with the price projected to jump to 0.04 or above. The average volatility of media hype impact on the company the price is over 100%. The price boost on the next news is estimated to be 14.29%, whereas the daily expected return is presently at 0.62%. The volatility of related hype on Appili Therapeutics is about 122571.43%, with the expected price after the next announcement by competition of 0.04. Appili Therapeutics has accumulated 8.18 M in total debt. Appili Therapeutics has a current ratio of 1.95, which is within standard range for the sector. Debt can assist Appili Therapeutics until it has trouble settling it off, either with new capital or with free cash flow. So, Appili Therapeutics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Appili Therapeutics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Appili to invest in growth at high rates of return. When we think about Appili Therapeutics' use of debt, we should always consider it together with cash and equity.Assuming the 90 days trading horizon the next estimated press release will be in a few days. Check out Appili Therapeutics Basic Forecasting Models to cross-verify your projections.Appili Therapeutics Related Hype Analysis
Having access to credible news sources related to Appili Therapeutics' direct competition is more important than ever and may enhance your ability to predict Appili Therapeutics' future price movements. Getting to know how Appili Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Appili Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| WMT | Walmart Inc CDR | 0.00 | 0 per month | 0.92 | 0.14 | 2.14 | (1.90) | 4.98 | |
| AMZN | Amazon CDR | 0.00 | 0 per month | 1.61 | 0.16 | 2.82 | (2.97) | 10.70 | |
| UPS | UPS CDR | 0.00 | 0 per month | 0.00 | (0.08) | 2.43 | (2.01) | 8.54 | |
| HD | HOME DEPOT CDR | 0.00 | 0 per month | 0.00 | (0.08) | 2.08 | (2.06) | 6.41 | |
| UNH | UnitedHealth Group CDR | (0.04) | 1 per month | 0.00 | (0.09) | 2.50 | (4.95) | 11.10 | |
| BRK | Berkshire Hathaway CDR | 0.00 | 0 per month | 0.00 | (0.05) | 1.22 | (1.72) | 7.42 | |
| COST | Costco Wholesale Corp | (0.45) | 3 per month | 0.87 | 0.05 | 1.80 | (1.80) | 5.29 | |
| JPM | JPMorgan Chase Co | (0.36) | 4 per month | 1.05 | 0.12 | 1.91 | (1.62) | 16.22 | |
| IBM | International Business Machines | 0.58 | 3 per month | 1.65 | 0.01 | 2.07 | (2.64) | 8.74 | |
| BN | Brookfield | 0.20 | 3 per month | 1.28 | 0.14 | 2.47 | (1.73) | 8.24 |
Appili Therapeutics Additional Predictive Modules
Most predictive techniques to examine Appili price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Appili using various technical indicators. When you analyze Appili charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Appili Therapeutics Predictive Indicators
The successful prediction of Appili Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Appili Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Appili Therapeutics based on analysis of Appili Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Appili Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Appili Therapeutics's related companies. | 2024 | 2025 (projected) | Payables Turnover | 0.002905 | 0.00276 | Days Of Inventory On Hand | 2.1K | 2.2K |
Story Coverage note for Appili Therapeutics
The number of cover stories for Appili Therapeutics depends on current market conditions and Appili Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Appili Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Appili Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Appili Therapeutics Short Properties
Appili Therapeutics' future price predictability will typically decrease when Appili Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Appili Therapeutics often depends not only on the future outlook of the potential Appili Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Appili Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 121.3 M | |
| Cash And Short Term Investments | 94.5 K |
Other Information on Investing in Appili Stock
Appili Therapeutics financial ratios help investors to determine whether Appili Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Appili with respect to the benefits of owning Appili Therapeutics security.